Ridgeback Capital
North America, New York, United States, New York
Description
Ridgeback Capital is a private investment company that is focused on investing in life science companies.
Investor Profile
Ridgeback Capital has made 30 investments, with 1 in the past 12 months and 20% as lead.
Stage Focus
- Post Ipo Equity (27%)
- Series B (27%)
- Series A (17%)
- Series C (17%)
- Series D (7%)
- Series E (3%)
- Series F (3%)
Country Focus
- United States (87%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (7%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Biopharma
- Oncology
- Genetics
- Life Science
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
